Intensity-modulated radiotherapy in patients with head and neck cancer: A European single-centre experience

British Journal of Radiology

Volumn 84, Issue 1000, 2011, Pages 367-374

  Van Gestel, Dirk ^a   Van Den Weyngaert, D ^a   Schrijvers, D ^b   Weyler, J ^a   Vermorken, J B ^c  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b MIDDELHEIM HOSPITAL   (Belgium)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOPLATIN; CISPLATIN; GEMCITABINE;

ADULT; AGED; AGEUSIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER RECURRENCE; DERMATITIS; DYSPHAGIA; FEMALE; FIBROSIS; HEAD AND NECK CANCER; HUMAN; INTENSITY MODULATED RADIATION THERAPY; LOCOREGIONAL RELAPSE FREE SURVIVAL; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; MUCOSAL DISEASE; OVERALL SURVIVAL; POSTOPERATIVE PERIOD; RADIATION DOSE; RADIATION INJURY; RETROSPECTIVE STUDY; SCORING SYSTEM; SKIN TOXICITY; XEROSTOMIA;

ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, SQUAMOUS CELL; EUROPE; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT SELECTION; RADIOTHERAPY DOSAGE; RADIOTHERAPY, INTENSITY-MODULATED; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TIME FACTORS; WAITING LISTS;

EID: 79952848112     PISSN: 00071285     EISSN: None     Source Type: Journal    
DOI: 10.1259/bjr/67058055     Document Type: Article

References (46)

1. Bourhis J, Overgaard J, Audry H, Ang KK, Saunders M, Bernier J, et al. Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 2006;368:843-54.
2. Budach W, Her T, Budach V, Belka C, Dietz K. A meta-analysis of hyperfractionated and accelerated radiotherapy and combined chemotherapy and radiotherapy regimens in unresected locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 2006;6:28.
3. Pignon JP, Bourhis J, Domenge C, Designe L. Chemotherapy added to loco-regional treatment for head and neck squamous cell carcinoma: three meta-analyses of update individual data. Lancet 2000;355:949-55. (Pubitemid 30148259)
4. Pignon JP, Le Maitre A, Maillard E, Bourhis J. Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): an update on 93 randomised trials and 17,346 patients. Radiother Oncol 2009;92:4-14.
5. Bachaud JM, Cohen-Jonathan E, Alzieu C, David JM, Serrano E, Daly-Schveitzer N, et al. Combined post-operative radiotherapy and weekly cisplatin infusion for locally advanced head and neck cancer carcinoma. Final report of a randomized trial. Int J Radiat Oncol Biol Phys 1996;36:999-1004. (Pubitemid 27014483)
6. Bernier J, Domenge C, Ozsahin M, Matuszewska K, Lefèbvre JL, Greiner RH, et al. Postoperative irradiation with or without concomitant chemotherapy for locally advanced Head and Neck Cancer. N Engl J Med 2004;350:1945-52. (Pubitemid 38580197)
7. Cooper JS, Pajak TF, Forastiere A, Jacobs J, Campbell BH, Saxman SB, et al. Postoperative concurrent radiotherapy and chemotherapy for high risk squamous cell carcinoma of the head and neck. N Engl J Med 2004;350:1937-44.
8. Bernier J, Cooper YS. Chemoradiation after surgery for high risk head and neck cancer patients: how strong is the evidence? Oncologist 2005;10:215-24.
9. Bonner JA, Harari PM, Giralt J, Azarnia N, Shin DM, Cohen RB, et al. Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck. N Engl J Med 2006;354:567-78. (Pubitemid 43209104)
10. Vermorken JB, Remenar E, van Herpen C, Gorlia T, Mesia R, Degardin M, et al. Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer. N Engl J Med 2007;357:1695-704. (Pubitemid 350005151)
11. Posner MR, Hershock DM, Blajman CR, Mickiewicz E, Winquist E, Gorbounova V, et al. Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer. N Engl J Med 2007;357:21-31.
12. Clark CH, Bidmead AM, Mubata CD, Harrington KJ, Nutting CM. Intensity-modulated radiotherapy improves target coverage, spinal cord sparing and allows dose escalation in patients with locally advanced cancer of the larynx. Radiother Oncol 2004;70:189-98. (Pubitemid 38353019)
13. Grégoire V, De Neve W, Eisbruch A, Lee N, Van den Weyngaert D, Van Gestel D. Intensity-modulated radiation therapy for head and neck carcinoma. Oncologist 2007;12:555-64. (Pubitemid 350012118)
14. Eisbruch A, ten Haken RK, Kim HM, Marsh LH, Ship JA. Dose volume and function relationships in parotid glands following conformal and intensity modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 1999;45:577-87. (Pubitemid 29462636)
15. Gregoire V, Maingon P. Intensity modulated radiation therapy in head and neck squamous cell carcinoma: state of art and future challenges. Cancer Radiother 2005;9:42-50. (Pubitemid 40445409)
16. Mendenhall WM, Amdur RJ, Palta JR. Intensity-modulated radiotherapy in the standard management of head and neck cancer: promises and pitfalls. J Clin Oncol 2006;24:2618-23. (Pubitemid 46622082)
17. Kam MK, Leung SF, Zee B, Chau RM, Suen JJ, Mo F, et al. Prospective randomized study of intensity-modulated radiotherapy on salivary gland function in early-stage nasopharyngeal carcinoma patients. J Clin Oncol 2007;25:4873-9. (Pubitemid 350220416)
18. Nutting C, A'Hern R, Rogers MS, Sydenham MA, Adab F, Harrington K. First results of a phase III multicenter randomized controlled trial of intensity modulated (IMRT) versus conventional radiotherapy (RT) in head and neck cancer (PARSPORT: ISRCTN48243537; CRUK/03/005) (abstract LBA6006). J Clin Oncol 2009;27:18s.
19. Corvo R. Evidence-based radiation oncology in head and neck squamous cell carcinoma. Radiother Oncol 2007;85:156-70. (Pubitemid 47562578)
20. Van den Steen D, Hulstaert F, Camberlin C. Intensiteitsgemoduleerde radiotherapie (IMRT). Health Technology Assessment (HTA). KCE reports 62A (D2007/10.273.32). Brussels, Belgium: Federaal Kenniscentrum voor de gezondheidszorg (KCE), 2007.
21. Verellen D, Vanhavere F. Risk assessment of radiation-induced malignancies based on whole-body equivalent estimates for IMRT treatment in the head and neck region. Radiother Oncol 1999;53:199-203.
22. Hall EJ. Intensity-modulated radiation therapy, protons, and the risk of second cancers. Int J Radiat Oncol Biol Phys 2006;65:1-7.
23. Rosenthal D, Chambers M, Fuller CD, Rebueno NC, Garcia J, Kies MS, et al. Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 2008;72:747-55.
24. Green FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG, et al, editors. AJCC cancer staging manual, 6th edn, New York, NY: Springer, 2002.
25. Gregoire V, Levendag P, Ang KK, Bernier J, Braaksma M, Budach V, et al. Selection and delineation of lymph node levels and related CTVs in the node-negative neck: DAHANCA, EORTC, GORTEC, NCIC, RTOG consensus guidelines. Radiother Oncol 2003;69:227-36. (Pubitemid 37485996)
26. International Commission on Radiation Units and Measurements. ICRU Report, 62. Prescribing, recording and reporting photon beam therapy (Supplement to ICRU report 50). Bethesda, MD: ICRU Publications, 2000.
27. Schaeken B, De Ost B, Van Gestel D, Janssens H, Van den Weyngaert D. Verification of the integral delivered dose for IMRT treatments in the head & neck region with alanine/ESR dosimetry. Proceedings of the 216th PTB seminar Alanine Dosimetry for Clinical Applications, 8-9 May 2006, Braunschweig: PTB. Bericht PTB-DOS-51.
28. Venselaar J, Welleweerd H, Mijnheer B. Tolerances for the accuracy of photon beam dose calculations of treatment planning systems. Radiother Oncol 2001;60:191-201. (Pubitemid 32601971)
29. Venselaar J, Welleweerd H. Application of a test package in an intercomparison of photon dose calculation performance of treatment planning systems used in clinical setting. Radiother Oncol 2001;60:203-13. (Pubitemid 32601972)
30. Specenier PM, Weyler J, Van Laer C, Van den Weyngaert D, Van den Brande J, Huizing MT, et al. A non-randomized comparison of gemcitabine-based chemoradiation with or without induction chemotherapy for locally advanced squamous cell carcinoma of the head and neck. BMC Cancer 2009;9:273.
31. Cox JD, Stetz J, Pajak TF. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) [editorial]. Int J Radiat Oncol Biol Phys 1995;31:1341-6.
32. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958;53:457-81.
33. Fowler JF, Lindstrom MJ. Loss of local control with prolongation in radiotherapy. Int J Radiat Oncol Biol Phys 1992;23:457-67.
34. Peters LJ, Withers HR. Applying radiobiological principles to combined modality treatment of head and neck cancer. The time factor. Int J Radiat Oncol Biol Phys 1997;13:403-26.
35. Seung S, Bae J, Solhjem M, Bader S, Gannett D, Hansen EK, et al. Intensity-modulated radiotherapy for head-and-neck cancer in the community setting. Int J Radiat Oncol Biol Phys 2008;72:1075-81.
36. Saba NF, Edelman S, Tighiouart M, Gaultney J, Davis LW, Khuri FR, et al. Concurrent chemotherapy with intensity-modulated radiation therapy for locally advanced squamous cell carcinoma of the larynx and oropharynx: a retrospective single-institution analysis. Head Neck 2009;31:1447-55.
37. Traynor Am, Richards GM, Hartig GK, Khuntia D, Cleary JF, Wiederholt PA, et al. Comprehensive IMRT plus weekly cisplatin for advanced head and neck cancer: The University of Wisconsin experience. Head Neck 2010;32:599-606.
38. Schoenfeld GO, Amdur RJ, Morris CG, Li JG, Hinerman RW, Mendenhall WM. Patterns of failure and toxicity after intensity-modulated radiotherapy for head and neck cancer. Int J. Radiat Oncol Biol Phys 2008;71:377-85.
39. Yao M, Dornfeld KJ, Buatti JM, Skwarchuk M, Tan H, Nguyen T, et al. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma - the University of Iowa experience. Int J Radiat Oncol Biol Phys 2005;63:410-21. (Pubitemid 41317157)
40. Klem ML, Mechalakos JG, Wolden Sl, Zelefsky MJ, Singh B, Kraus D, et al. Intensity-modulated radiotherapy for had and neck cancer of unknown primary: toxicity and preliminary efficacy. Int J Radiat Oncol Biol Phys 2008;70:1100-7. (Pubitemid 351296099)
41. Lee NY, O'Meara W, Chan K, Della-Bianca C, Mechalakos JG, Zhung J, et al. Concurrent chemotherapy and intensity-modulated radiotherapy for locoregionally advanced laryngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys 2007;69:459-68. (Pubitemid 47380087)
42. Chao KS, Ozyigit G, Tran BN, Cengiz M, Dempsey JF, Low DA. Patters of failure in patients receiving definitive and postoperative IMRT for head-and-neck cancer. 2003;55:312-21.
43. Richetti A, Cianchetti M, Fogliata A, Cozzi L, Ciernik I, Bernier J. Intensity modulated radiation therapy in patients with head and neck cancer: the experience of the oncology institute of southern Switzerland. Radiother Oncol 2007;82:S61-2.
44. Lambrecht M, Dirix P, Van den Bogaert W, Nuyts S. Incidence of isolated regional recurrence after definitive (chemo-)radiotherapy for head and neck squamous cell carcinoma. Radiother Oncol 2009;93:498-502.
45. Dirix P, Nuyts S. Value of intensity-modulated radiotherapy in stage IV head and neck squamous cell carcinoma. Int J Radiat Oncol Biol Phys (in press).
46. EMEA (Data on file), Erbitux-H-558-II-05. Available at: http://www.ema.europa.eu/docs/eu-GB/document-library/EPAR---scientific- discussion---variation/human/000558/wc500029116.pdf